Cell-type specific changes in perisomatic inhibition in an animal model of temporal lobe epilepsy
Cell-type specific changes in perisomatic inhibition in an animal model of temporal lobe epilepsy
批准号:
405864679
负责人:
Professor Dr. Tengis Gloveli
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2022-12-31
中文摘要
癫痫网络中癫痫发作产生的主要机制是兴奋和抑制平衡的改变。事实上,有强有力的证据表明,树突抑制在动物模型中减少,以及在颞叶癫痫(TLE)患者中。相反,体周抑制保持不变甚至增加。然而,体周抑制由两种类型的GABA能中间神经元提供,它们表达小清蛋白(PV)或胆囊收缩素(CCK)。PV篮状细胞(BC)显示快速尖峰放电,并介导快速的,“阶段性”的抑制形式,这有助于精确的时间放电和振荡同步在皮层网络。相比之下,CCK BC显示出较低频率、规则的放电,并介导较慢的(“强直性”)、行为状态依赖性抑制和调节神经元兴奋性。 我们建议,这两种BC类型的差异影响癫痫发作的出现和疾病的进展作出贡献:抑制CCK BCs变得减少,因此神经元兴奋性增加,癫痫发作的阈值变得降低。相反,PV BC的抑制作用得以维持甚至增加。然而,PV BC介导的抑制不能抵消更高的兴奋性,而是促进同步化和高频振荡,导致改变的节律发生。这种机制可能会增强癫痫发作的产生,至少部分地解释了为什么药物增强抑制不能防止癫痫发作在一些patients.To测试这些假设,我们将采用一种结合神经解剖学,电生理学和计算的方法,专注于慢性小鼠模型TLE。我们将使用体视学方法描述控制和癫痫海马中PV和CCK BCs的数量、细胞分布和突触连接的变化。我们将研究内在和突触特性的变化,特别是代谢型受体(如GABAB受体)对GABA能输出和突触后兴奋性的调节。这些生理调查将补充定量免疫电镜分析的超微结构和分子变化。最后,我们将使用体外切片和计算网络模型分析细胞和突触特性的改变以及BCs中GABAB受体的突触前和突触后分布如何影响微电路相互作用,并导致节律发生的改变和癫痫发作的产生。结果将有助于我们理解PV和CCK BCs介导的体周抑制中涉及的细胞和突触机制的分歧。以及它们在TLE中的不同作用。此外,我们将获得重要的见解,改变节律和癫痫发作的产生机制,在TLE,可以帮助我们更好地了解耐药性,并确定新的治疗途径
英文摘要
A major mechanism underlying seizure generation in epileptic networks is an altered balance of excitation and inhibition. In fact, there is strong evidence that dendritic inhibition is reduced in animal models, as well as in human patients with temporal lobe epilepsy (TLE). In contrast, perisomatic inhibition remains unchanged or even increase. However, perisomatic inhibition is provided by two types of GABAergic interneuron which express either parvalbumin (PV) or cholecystokinin (CCK). PV basket cells (BCs) show fast-spiking firing and mediate a rapid, “phasic”-form of inhibition which contributes to the precise timing of discharge and oscillatory synchronization in cortical networks. In contrast, CCK BCs show lower-frequency, regular firing and mediate slower (“tonic”), behavior state-dependent inhibition and modulate neuronal excitability. We propose that the two BC types are differentially affected in epilepsy and contribute to the emergence of seizures and the progression of the disease: inhibition by CCK BCs becomes diminished, therefore neuronal excitability increases and the threshold for seizure generation becomes reduced. In contrast, inhibition by PV BCs is maintained or even increased. However, PV BC-mediated inhibition cannot counterbalance the higher excitability, but rather promotes synchronization and high frequency oscillations, leading to altered rhythmogenesis. Such a mechanism could potentiate seizure generation explaining, at least partially, why drugs enhancing inhibition cannot prevent seizures in some patients.To test these hypotheses, we will apply a combined neuroanatomical, electrophysiological and computational approach focusing on a chronic mouse model of TLE. We will characterize changes in the number, cellular distribution and synaptic connectivity of PV- and CCK BCs in control and epileptic hippocampus using stereological methods. We will investigate changes in the intrinsic and synaptic properties, in particular the regulation of the GABAergic output and postsynaptic excitability by metabotropic receptors, such as GABAB receptors. These physiological investigations will be complemented by quantitative immuno-electron microscopic analysis of ultrastructural and molecular changes. Finally we will analyze how the altered cellular and synaptic properties and the pre- and postsynaptic distribution of GABAB receptors in BCs influence microcircuit interactions and lead to altered rhythmogenesis and the generation of seizures using in vitro slice and computational network models.Results will contribute to our understanding of the divergence of cellular and synaptic mechanisms involved in perisomatic inhibition meditated by PV- and CCK BCs, as well as their differential role in TLE. Furthermore, we will obtain important insights into the mechanisms of altered rhythmogenesis and seizure generation in TLE that can help us better understand drug resistance and identify new therapeutic avenues
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Dynamic of axonal activity during fast network oscillations and plasticity
-
批准号:161844901
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2010
-
负责人:Professor Dr. Tengis Gloveli
-
依托单位:
国内基金
海外基金
登录
查看更多内容
铋基邻近双金属位点Type B异质结光热催化合成氨机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:30.0万元
-
批准年份:2024
-
负责人:黎景卫
-
依托单位:
盐皮质激素受体抑制2型固有淋巴细胞活化加重心肌梗死后心室重构的作用机制
-
批准号:82372202
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:侯旭敏
-
依托单位:
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
-
批准号:82371721
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王星云
-
依托单位:
GPSM1介导Ca2+循环-II型肌球蛋白网络调控脂肪产热及代谢稳态的机制研究
-
批准号:82370879
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:严婧
-
依托单位:
二型聚合函数基于扩展原理的构造与表示问题
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:张炜
-
依托单位:
真菌中I型-III型聚酮杂合类天然产物的基因组挖掘
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:孔德坤
-
依托单位:
智能型Type-I光敏分子构效设计及其抗耐药性感染研究
-
批准号:22207024
-
项目类别:青年科学基金项目(C类)
-
资助金额:20.0万元
-
批准年份:2022
-
负责人:赵琦
-
依托单位:
TypeⅠR-M系统在碳青霉烯耐药肺炎克雷伯菌流行中的作用机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:蒋晓飞
-
依托单位:
替加环素耐药基因 tet(A) type 1 变异体在碳青霉烯耐药肺炎克雷伯菌中的流行、进化和传播
-
批准号:LY22H200001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:蔡加昌
-
依托单位:
面向手性α-氨基酰胺药物的新型不对称Ugi-type 反应开发
-
批准号:LY22B020003
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:李绍玉
-
依托单位: